NCT01887613View on ClinicalTrials.gov

Specified Drug Use-Results Survey of Regnite

CompletedOBSERVATIONAL
Enrollment

1,597

Participants

Timeline

Start Date

October 1, 2012

Primary Completion Date

February 28, 2019

Study Completion Date

February 28, 2019

Conditions
Restless Legs Syndrome
Interventions
DRUG

Regnite

oral

Trial Locations (7)

Unknown

Chūbu

Hokkaido

Kansai

Kantou

Kyushu

Shikoku

Tōhoku

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT01887613 - Specified Drug Use-Results Survey of Regnite | Biotech Hunter | Biotech Hunter